Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042224
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2002-07-24
Brief Title:
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
Sponsor:
Northwell Health
Organization:
Northwell Health
Study Overview
Official Title:
ECT in Clozapine Refractory Schizophrenia
Status:
COMPLETED
Status Verified Date:
2017-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate electroconvulsive therapy ECT in patients who have not responded adequately to clozapine
Detailed Description:
ECT augmentation of clozapine will be compared to clozapine monotherapy in schizophrenic patients who continue to have psychotic symptoms despite optimal treatment with clozapine
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DSIR AT-SO | OTHER | NorthShore LIJ Health System | httpsreporternihgovquickSearchR01MH060390 |
| R01MH060390 | NIH | None | None |